FEDERAL TRADE COMMISSION v. SURESCRIPTS, LLC

  1. May 22, 2020

    Surescripts Can't Take FTC Monopoly Case To DC Circ. Yet

    Electronic prescription service Surescripts won't get the chance to have the D.C. Circuit answer two questions it says are vital to get sorted before the Federal Trade Commission's case accusing it of illegally maintaining a monopoly can move forward.

  2. March 30, 2020

    FTC Fights Surescripts' Bid For DC Circuit Appeal

    The Federal Trade Commission has urged a D.C. federal court not to allow Surescripts an immediate appeal of its lost dismissal bid, arguing that the questions the electronic prescription provider is trying to raise would not move the monopolization case any closer to a conclusion.

  3. March 09, 2020

    Surescripts Wants DC Circ. To Review FTC Antitrust Suit

    Electronic prescription service Surescripts says the D.C. Circuit needs to weigh in on two key questions before the Federal Trade Commission's case accusing it of using contract terms to illegally maintain a monopoly can move forward.

  4. February 27, 2020

    Surescripts Can't Limit Discovery In FTC Case

    Potential overlap with consolidated proposed class actions wasn't enough for a D.C. federal judge on Thursday to limit discovery in the Federal Trade Commission's case accusing Surescripts of using contract terms and other tactics to illegally maintain its monopoly over electronic prescription services.

  5. January 17, 2020

    Surescripts Can't Sink FTC's Monopoly Case

    A D.C. federal court ruled Friday that Surescripts LLC can't kill a case brought by the Federal Trade Commission, which accused the company of using contract terms and other tactics to illegally maintain its monopoly over electronic prescription services.

  6. January 13, 2020

    Surescripts Says High Court Petitions Could Resolve FTC Row

    Surescripts LLC has told a D.C. federal court that the Federal Trade Commission's monopolization case against it could be resolved if the U.S. Supreme Court decides the agency isn't allowed to seek monetary relief in one of several unrelated cases currently on petition.

  7. September 16, 2019

    Court Is Wrong Place For Monopoly Case, E-Scrip Co. Says

    Surescripts has again urged a D.C. federal judge to reject the Federal Trade Commission's suit over an alleged e-prescription monopoly, arguing that the FTC can't just claim "we know it when we see it" in deciding which legal actions are suited for federal court rather than a commission in-house adjudicatory hearing.

  8. August 26, 2019

    FTC Fights E-Prescription Co. Bid To Nix Monopoly Case

    The Federal Trade Commission pushed back against Surescripts' bid to nix a suit accusing the company of monopolizing the electronic prescription market, telling a D.C. federal court that under the FTC Act the court does have the jurisdiction to hear the case.

  9. July 15, 2019

    E-Prescription Co. Hopes To Zap FTC Monopoly Case

    Surescripts has told a D.C. federal court that the court lacks jurisdiction to hear a Federal Trade Commission suit accusing the company of dominating the electronic prescription market with competition-killing tactics, and says the agency can't prove its case anyway.

  10. April 24, 2019

    FTC Accuses Electronic Prescription Co. Of Monopolization

    The Federal Trade Commission said Wednesday that it has sued Surescripts in D.C. federal court over allegations that the company uses contract terms and other tactics to illegally maintain its monopoly over electronic prescription services.